Immunosuppressive analogues and derivatives of succinylacetone
US5252603A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Dec 6, 1990 |
| Grant date | Oct 12, 1993 |
| Priority date | — |
| Expiry date | Dec 6, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/41
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Succinylacetone derived or related medicaments and methods of synthesis of the same are shown wherein the medicaments consists of succinylacetonyl-proline-PEG, succinylacetonyl-NH-PEG, or compounds that have the formula: ##STR1## wherein n=1-6 PA1 R=CH.sub.3, CF.sub.3, --CO.sub.2 R.sup.IV, ##STR2## R.sup.I, R.sup.II =H, F, CH.sub.3, or ##STR3## R.sup.III =H, ##STR4## or tetrazolyl R.sup.IV =H, or alkyl and that have immunosuppressive activity both in vivo and in vitro based on their activities in cellular immunologic assays and adjuvant induced arthritis in rats, respectively.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.